HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

HI-6 therapy and the acute phase response in the rat.

Abstract
The propensity of therapeutic doses of HI-6 (50 mg/kg) in combination with atropine sulphate (17 mg/kg), antidotes used to treat organophosphate poisoning, to induce the acute phase response (APR) in the laboratory rat was examined. A single intraperitoneal injection of HI-6, either alone or with atropine, caused a rapid doubling of the plasma corticosterone concentration. However, this increase was short-lived in comparison with corticosterone kinetics during the typical, turpentine-induced APR. The elevated glucocorticosteroid concentration did not affect acute phase protein (APP) gene transcription or mRNA and protein synthesis in the livers of oxime/atropine-treated rats. On the basis of these findings, we concluded that the administered doses of HI-6 and atropine did not induce the generalised, non-specific APR.
AuthorsS Ivanović-Matić, G Poznanović
JournalToxicology (Toxicology) Vol. 106 Issue 1-3 Pg. 11-7 (Jan 08 1996) ISSN: 0300-483X [Print] Ireland
PMID8571381 (Publication Type: Journal Article)
Chemical References
  • Acute-Phase Proteins
  • Antidotes
  • Blood Proteins
  • Oximes
  • Pyridinium Compounds
  • RNA, Messenger
  • Atropine
  • Soman
  • asoxime chloride
  • Corticosterone
  • Turpentine
Topics
  • Acute-Phase Proteins (biosynthesis, genetics)
  • Acute-Phase Reaction (chemically induced)
  • Animals
  • Antidotes (administration & dosage, therapeutic use, toxicity)
  • Atropine (administration & dosage, therapeutic use, toxicity)
  • Blood Proteins (biosynthesis)
  • Blotting, Northern
  • Corticosterone (blood)
  • Immunoelectrophoresis
  • Injections, Intraperitoneal
  • Liver (metabolism)
  • Male
  • Oximes
  • Pyridinium Compounds (administration & dosage, therapeutic use, toxicity)
  • RNA, Messenger (analysis)
  • Rats
  • Rats, Wistar
  • Soman (poisoning)
  • Turpentine (toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: